Suchergebnisse - "Valladares-Ayerbes, Manuel"

PubPharm (99)

1

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer : the PERSEIDA (Cohort 2) study

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Valladares-Ayerbes, M. | Safont, M. | González Flores, E. | +18

2

Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Rodríguez-Lescure, �. | Gallego, J. | Garcia-Alfonso, P. | +19

3

Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

enthalten in: The New England journal of medicine | 2023

von Prager, G. | Taieb, J. | Fakih, M. | +118

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):504. - PMID 37198414

4

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment : The PERSEIDA Study

enthalten in: Cancers | 2022

von Valladares-Ayerbes, M. | Garcia-Alfonso, P. | Muñoz Luengo, J. | +20

5

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Argilés, G. | Mulet, N. | Valladares-Ayerbes, M. | +58

6

Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status : Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2022

von Benavides, M. | Gómez-España, A. | García-Alfonso, P. | +17

7

Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer : the POLAF trial

enthalten in: British journal of cancer | 2022

von Élez, E. | Gómez-España, M. | Grávalos, C. | +17

8

Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer

enthalten in: Clinical colorectal cancer | 2021

von Sartore-Bianchi, A. | García-Alfonso, P. | Geissler, M. | +8

9

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma : the BIBABRAX study

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Feliu, J. | Jorge Fernández, M. | Macarulla, T. | +14

10

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer : A Retrospective Pooled Analysis

enthalten in: Drugs & aging | 2021

von García-Alfonso, P. | Díaz-Rubio, E. | Abad, A. | +118

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]